| 2026-06-14 19:30 | UU:AAPG | | News Release200 | Ascentage Pharma Presents Multiple Clinical Updates at EHA2026 Congress |
| 2026-06-14 19:19 | UU:EXC | | News Release200 | ComEd Reaches 99% Restoration Following Multi-Day Severe Storm Event |
| 2026-06-14 19:03 | UU:CVM | | News Release200 | CEL-SCI Corporation Announces Pricing of Offering |
| 2026-06-14 18:05 | UU:ZYME | | News Release200 | Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting ADC ZW191 at ESMO Gynaecological Cancers Congress 2026 |
| 2026-06-14 17:00 | UU:PMETF | | News Release200 | Concept Study Identifies Potential Refining Pathway at Shaakichiuwaanaan to Battery-Grade Lithium Carbonate |
| 2026-06-14 17:00 | UU:PMETF | | News Release200 | Concept Study Identifies Potential Refining Pathway at Shaakichiuwaanaan to Battery-Grade Lithium Carbonate |
| 2026-06-14 17:00 | UU:OSK | | News Release200 | Oshkosh Defense Highlights Proven, Adaptable Tactical Mobility Solutions for Europe at Eurosatory 2026 |
| 2026-06-14 16:35 | UU:MIRM | | News Release200 | Mirum Pharmaceuticals and Incyte Announce Positive Pivotal Phase 2 Results from PROGRESS Study of Zilurgisertib in Fibrodysplasia Ossificans Progressiva |
| 2026-06-14 16:35 | UU:INCY | | News Release200 | Mirum Pharmaceuticals and Incyte Announce Positive Pivotal Phase 2 Results from PROGRESS Study of Zilurgisertib in Fibrodysplasia Ossificans Progressiva |
| 2026-06-14 16:30 | UU:CRNX | | News Release200 | Crinetics Presents Full Results From Phase 2 Trial of Atumelnant in Congenital Adrenal Hyperplasia (CAH) in Oral Presentation at ENDO 2026 |
| 2026-06-14 15:26 | UU:ELEK | | News Release200 | Elektros Inc. Advances Its Lithium and EV Innovation Strategy as Global Electrification Momentum Accelerates |
| 2026-06-14 14:55 | UU:ELEK | | News Release200 | Elektros Inc. Strengthens Its Position in Lithium and EV Innovation as the Global Electrification Era Gains Momentum |
| 2026-06-14 14:45 | UU:CRNX | | News Release200 | Crinetics Presents Long Term Data at ENDO 2026 Confirming PALSONIFY(TM) (paltusotine) Provides Durable, Consistent Acromegaly Control |
| 2026-06-14 14:36 | UU:ELEK | | News Release200 | Elektros Inc. Highlights Long-Term Lithium and EV Innovation Strategy as Global Investors Focus on the Future of Electrification |
| 2026-06-14 14:15 | UU:ELEK | | News Release200 | Elektros Inc. Embraces the Bright Future of Lithium and EV Innovation as Its Global Electrification Mission Continues to Advance |
| 2026-06-14 11:45 | UU:AVAV | | News Release200 | AV Introduces TOM 50 RE, a Backpackable UGV for Rapid Reconnaissance and Explosive Ordnance Disposal |
| 2026-06-14 10:21 | UU:CLDX | | News Release200 | Celldex Presents Long-Term Barzolvolimab Results Demonstrating Sustained Off-Treatment Improvement in Angioedema in Patients with CSU at the European Academy of Allergy and Clinical Immunology Annual Meeting |
| 2026-06-14 10:00 | UU:UPB | | News Release200 | Upstream Bio Presents New Responder Analyses Demonstrating Clinically Meaningful Improvements in CRSwNP in Significant Majority of Participants Treated with Verekitug in the Phase 2 VIBRANT Trial at EAACI 2026 |
| 2026-06-14 10:00 | UU:MLYS | | News Release200 | Mineralys Therapeutics Presents Late-Breaking Data on Lorundrostat and Heart Failure Risk Biomarkers at The Endocrine Society Annual Meeting (ENDO 2026) |
| 2026-06-14 05:15 | UU:CLDX | | News Release200 | Celldex Presents Positive First-in-Human Results from Phase 1 Study of Novel Bispecific CDX-622 at the European Academy of Allergy and Clinical Immunology Annual Meeting |
| 2026-06-14 03:15 | UU:LLY | | News Release200 | Lilly's Jaypirca (pirtobrutinib) significantly reduced the risk of disease progression or death by 45% when added to a venetoclax time-limited regimen in people with previously treated CLL/SLL |
| 2026-06-14 03:15 | UU:LEGN | | News Release200 | Legend Biotech Establishes Clinical Proof-of-Concept for LB2501, a Potential First-in-Class In Vivo CD19/CD20 Dual-Targeting CAR-T, in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma |
| 2026-06-13 22:16 | UU:ELEK | | News Release200 | Elektros Inc. Ignites New Momentum Across Lithium, EV Innovation, and Critical Minerals as the Global Electrification Era Accelerates |
| 2026-06-13 21:30 | UU:ELEK | | News Release200 | Elektros Inc. Powers Ahead as Global Demand for Lithium, EV Innovation, and Critical Minerals Creates New Opportunities for Electrification |
| 2026-06-13 21:15 | UU:ELEK | | News Release200 | Elektros Inc. Accelerates Its Vision for Lithium, EV Innovation, and the Future of Electrification |
| 2026-06-13 21:00 | UU:ELEK | | News Release200 | Powering the Future of Electrification |
| 2026-06-13 20:00 | UU:ACDVF | | News Release200 | Air Canada and the IAMAW Reach Tentative Agreement on New Contract |